Tehmasp Rehman Mirza

8PUBLICATIONS
29CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Pharmaceutical delivery technologiesGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2026
Fatal Cardiogenic Shock in Patients with Heart Failure: National Mortality Trends, Forecasting, and the Influence of Atherosclerotic Cardiovascular Disease in the United States in 1999-2023.

|Jul 28, 2026
Comparison of the Safety and Effectiveness of Apixaban Versus Rivaroxaban in Acute Venous Thromboembolism: A Propensity-Matched Real-World TriNetX Study with Obesity and Cancer Subgroup Analyses.

|Jun 26, 2026
Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

|Jun 25, 2026
Cardiovascular Outcomes with Colchicine in Coronary Artery Disease and HFpEF: A Propensity-Matched TriNetX Analysis.

|May 27, 2026
Comparative Effectiveness of Finerenone Versus SGLT2 Inhibitors in Patients with HFpEF and CKD: A Real-World Propensity-Matched TriNetX Analysis.

|Feb 18, 2026
Rising trends in obesity and cancer-related mortality in the United States: a population-based analysis, 1999-2020.

Faizan Ahmed, Tehmasp Rehman Mirza, Mohamed Bakr

Pageof 2

Frequent Collaborators

5 joint publications

Haris Bin Tahir

5 joint publications

Muhammad Abdullah

4 joint publications

Najam Gohar

4 joint publications

Muhammad Hussain